Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow12.55 M USD-11.90 M USD-9.52 M USD-5.34 M USD439000 USD-731000 USD-413000 USD1.21 M USD-543180 USD-14.41 M USD-9.10 M USD-7.32 M USD
Depreciation & Amortization5.22 M USD4.22 M USD3.17 M USD1.29 M USD1.33 M USD2.08 M USD3.14 M USD6.59 M USD8.41 M USD7.24 M USD4.89 M USD952320 USD
Stock-Based Compensation2.89 M USD4.12 M USD2.74 M USD2.46 M USD2.21 M USD1.08 M USD515000 USD694000 USD211809 USD522987 USD836741 USD935316 USD
Capital Expenditures2.38 M USD4.11 M USD1.46 M USD1.76 M USD2.12 M USD1.54 M USD879000 USD624000 USD1.64 M USD5.83 M USD2.26 M USD299978 USD
Cash Flow from Investing7.90 M USD-3.73 M USD-24.78 M USD-1.56 M USD-1.89 M USD-1.30 M USD-544000 USD-367000 USD-1.61 M USD-5.82 M USD-73.57 M USD-298352 USD
Cash Flow from Financing-9.57 M USD16.07 M USD19.69 M USD9.02 M USD17.50 M USD-861000 USD-603000 USD3.10 M USD2.43 M USD16.43 M USD84.57 M USD9.04 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow10.16 M USD-16.01 M USD-10.97 M USD-7.11 M USD-1.68 M USD-2.28 M USD-1.29 M USD588000 USD-2.18 M USD-20.24 M USD-11.36 M USD-7.62 M USD

Xtant Medical Holdings Inc. is a leading company in the medical device sector, specializing in the development and distribution of regenerative medicine products and surgical implants. The core purpose of the company is to improve patient outcomes through innovative solutions in orthopedic and neurological surgery. Xtant Medical’s product offerings include biologics and other advanced materials designed to support the healing and repair of tissue, primarily within the spine and broader orthopedics market. Their products are integral in the treatment of complex injuries and conditions, playing a crucial role in both surgical intervention and recovery processes. Based in the healthcare industry, Xtant Medical Holdings Inc. serves hospitals, surgical centers, and clinics, providing essential tools for managing patient care. In the financial market, Xtant's products and innovations position the company as a critical provider within the medical technology landscape, underlining its market presence and influence in advancing medical treatments.